Condition: Nerve Sheath Tumor · Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The goal of this clinical trial is to evaluate the efficacy and safety of FCN-159 in patients with specific NF2-associated nerve sheath tumors.
This description comes directly from the study's public registry record.
Ning Li, M.D. · +86 135-5271-5820 · yalejiang@cicams.ac.cn
Always discuss trial participation with your own doctor first.
| Shuhang Wang | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06553365